🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Apathy is a neurocognitive syndrome characterized by reduced goal-directed ...
Status
Recruiting
Location
Bordeaux University Hospital
Start Date
2021-04-13
Trial ID
NCT03998852
The purpose of this study is to gather observational data on an already FDA...
Status
Completed
Location
San Francisco VA Medical Center
Start Date
2003-07
Trial ID
NCT00792532
Treatments Being Tested
This is a prospective investigation which aims to address key challenges to...
Status
Completed
Location
University of Wisconsin
Start Date
2021-09-13
Trial ID
NCT04818060
Treatments Being Tested
The primary goal of this project is to study the feasibility of a prototype...
Status
Terminated
Location
Stanford University
Start Date
2022-07-01
Trial ID
NCT04954248
Treatments Being Tested
The purpose of the GenderBOLD study is to shed light on the mechanisms resp...
Status
Completed
Location
CHUV, nephrology service
Start Date
2017-05-30
Trial ID
NCT04085094
This pilot clinical trial studies advanced magnetic resonance imaging (MRI)...
Status
Terminated
Location
Vanderbilt-Ingram Cancer Center
Start Date
2012-05
Trial ID
NCT01996527
Squamous cell carcinoma (SCC) could be a very aggressive cancer and has a b...
Status
Unknown
Location
CHU Amiens
Start Date
2024-03-27
Trial ID
NCT06450080
Treatments Being Tested
Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's diseas...
Status
Completed
Location
Multiple Locations
Start Date
2005-06
Trial ID
NCT00249080
Patients with osteoarthritis of the knee undergo visible joint changes in r...
Status
Completed
Location
Multiple Locations
Start Date
2013-05
Trial ID
NCT03644420
This prospective phase II study assesses the accuracy of second generation ...
Status
Completed
Location
University of Alberta
Start Date
2022-02-10
Trial ID
NCT05141760
Treatments Being Tested